Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    4.00 (0.51%)
Bid:
774.00
Ask:
780.00
Spread: 6.00 (0.775%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close Trading Update and Acquisition

8 Dec 2017 07:00

RNS Number : 7434Y
Porvair PLC
08 December 2017
 

For immediate release 8 December 2017

 

 

Porvair PLC

 

Pre-close trading update and acquisition

 

Porvair plc ("Porvair", "the Group" or "the Company"), the specialist filtration and environmental technologies group, announces the following trading update and acquisition ahead of its close period for the year ended 30 November 2017.

Trading update

Revenue growth for the year ended 30 November 2017 was 6%. Underlying revenue(1) growth was 11% overall, with underlying revenue growth of 13% in the Microfiltration division and 1% in the Metals Filtration division. Earnings for the year are forecast to be ahead of management's expectations.

Net cash at the 30 November 2017 was £9.7 million (2016: £13.6 million), after capital and acquisition expenditure of approximately £11 million. Group order books for the start of the 2018 financial year are healthy. 

New divisional structure

Recognising the Group's growth in recent years, and as noted in the 2017 interim report, the Board will change the Group's management and reporting structure in 2018 to one that offers better management and market focus and greater investor clarity. The 2017 Report and Accounts will use the current two division structure, but will include proforma information for the new three new divisions, which will serve distinct markets: Aerospace & Industrial; Laboratory; and Molten Metals.

Acquisition

The new Laboratory division, which will focus on filtration and sample preparation products, acquired Rohasys B.V., a Dutch company, on 7 December 2017. This small acquisition brings robotic sample handling expertise to the division, which will enhance the Group's growing bioscience sample preparation capabilities.

Date of preliminary announcement

Porvair will announce its preliminary results for the year ended 30 November 2017 on Monday 29 January 2018.

Market Abuse Regime

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

Note (1) Underlying revenue: Revenue at constant currency excluding the impact of large projects.

 

For further information, please contact:

Porvair plc

 

01553 765 500

Ben Stocks, Chief Executive

 

 

Chris Tyler, Group Finance Director

 

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, separation and environmental technologies businesses. Its products are used in a range of niche filtration and separation markets, and are derived from its expertise in the design and manufacture of filtration and separation systems. From the 2018 financial year it is organised into three divisions: Aerospace & Industrial; Laboratory; and Molten Metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUBUNRBAAURAA
Date   Source Headline
7th Mar 20169:01 amRNSHolding(s) in Company
7th Mar 20169:00 amRNSHolding(s) in Company
1st Feb 201611:38 amRNSDirector/PDMR Shareholding
25th Jan 20167:00 amRNSFull Year Results
7th Dec 20157:00 amRNSPre-close trading update and acquisition
17th Sep 20154:15 pmRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSTrading Update
12th Aug 20151:15 pmRNSHolding(s) in Company
12th Aug 20151:11 pmRNSHolding(s) in Company
10th Jul 201512:45 pmRNSDirector/PDMR Shareholding
29th Jun 20157:00 amRNSInterim Results
23rd Jun 20155:00 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSTrading Update
29th May 20155:31 pmRNSTotal Voting Rights
30th Apr 20157:02 amRNSDirector declaration
14th Apr 20152:55 pmRNSAGM resolutions
14th Apr 20157:00 amRNSAGM Statement and Trading Update
24th Mar 20152:25 pmRNSPosting of Accounts
11th Mar 20157:00 amRNSHolding(s) in Company
5th Feb 20157:00 amRNSHolding(s) in Company
30th Jan 20154:03 pmRNSEx-Dividend Date
27th Jan 201512:11 pmRNSDirectors' Shareholdings and Issue of Equity
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.